Effect of Activated Charcoal on Rivaroxaban Pharmacokinetics in Healthy Subjects : RICHAR Study
Phase of Trial: Phase I
Latest Information Update: 02 Dec 2016
At a glance
- Drugs Charcoal (Primary) ; Rivaroxaban (Primary)
- Indications Thromboembolism; Thrombosis
- Focus Pharmacokinetics
- Acronyms RICHAR
- 02 Dec 2016 Results of this trial, published in the Clinical Pharmacokinetics journal.
- 24 May 2016 Status changed from recruiting to completed.
- 04 Feb 2016 New trial record